Cite
HARVARD Citation
Beelen, D. et al. (2022). Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial. American journal of hematology. 97 (8), pp. 1023-1034. [Online].